retatrutide phase 2 trial type 2 diabetes weight loss 2024 with as compared to licenced obesity 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

It is studied in research into body weight regulation, fat metabolism, appetite regulation and glucose metabolism, thanks to its combined activity at the GLP-1, GIP and glucagon receptor

However, there is an important detail people should understand: There have not yet been large direct head-to-head trials comparing retatrutide and tirzepatide under identical conditions

The overall safety profile of dapagliflozin was consistent across the studied indications

How big is the market

Interestingly, GLP-1RA antidiabetic drugs have shown a distinct effect in reducing the incidence of stroke and enhancing neuroprotection in both pre-clinical and clinical studies (80, 81)